Related Experiment Videos
Activation of complement in the skin after PUVA therapy
Acta Dermato-Venereologica
|January 1, 1984
Summary
Photochemotherapy with PUVA significantly increases complement C3 split products in skin, indicating complement activation. This may contribute to delayed erythema after long-wave ultraviolet light exposure.
Area of Science:
- Dermatology
- Immunology
- Photobiology
Background:
- Complement activation is a key immune response.
- Ultraviolet (UV) radiation can trigger immune reactions in the skin.
- Delayed erythema after UV exposure suggests inflammatory processes.
Purpose of the Study:
- To investigate complement activation following UVA and PUVA treatment.
- To determine if complement C3 split products increase after UV irradiation.
- To explore the role of complement in UV-induced delayed erythema.
Main Methods:
- Collected suction blister fluid from the abdominal skin of 14 healthy subjects.
- Measured split products of complement C3 (C3-split) as a marker of complement activation.
- Analyzed C3-split levels before and after UVA or PUVA treatment in both irradiated and non-irradiated skin areas.
Main Results:
- PUVA treatment led to a significant increase in C3-split products (p < 0.05) in both irradiated and non-irradiated skin.
- UVA treatment resulted in a less pronounced increase in C3-split products compared to PUVA.
- Elevated C3-split levels suggest complement activation occurred after UV exposure.
Conclusions:
- Complement activation, indicated by increased C3-split products, is associated with PUVA therapy.
- Complement activation may play a significant role in the delayed erythema observed after long-wave UV light exposure.
- These findings highlight the involvement of the complement system in the skin's response to phototherapy.